Search results
Merck Prepares to Take on Pfizer After Pneumococcal Vaccine Approval
Barrons.com· 3 days agoPfizer currently dominates the market for pneumococcal vaccines, which protect against bacterial...
US FDA approves Merck's pneumococcal vaccine for adults
Reuters· 4 days ago, opens new tab said on Monday the U.S. Food and Drug Administration has approved its...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 17 hours agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
NBC New York· 4 days agoThe Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria...
MSD competes with Pfizer in pneumococcal vaccine market after FDA approval
Pharmaceutical Technology via Yahoo Finance· 3 days agoMSD’s 21-valent pneumococcal vaccine introduces a new rival to Pfizer’s 20-valent product Prevnar 20...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 3 days agoFDA and CDC, Novavax intends to market this updated COVID-19vaccine in pre-filled syringes by...
Merck’s vaccine approval poses threat to one of Pfizer’s top-selling products
Market Watch· 4 days ago“We’ll provide protection that’s broader than anything that’s out there,” Art Hirt, senior vice...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 16 hours agoThe vaccine, dubbed...older adults it can be serious or even deadly. Moderna will rival Pfizer and...
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
BioPharma Dive via Yahoo Finance· 3 days agoBut it’s Pfizer’s Prevnar shots that have dominanted the market. The company’s Prevnar...for adults...
New Pneumococcal Vaccine Approved
Medscape· 3 days agoThe new vaccine covers eight serotypes not protected by other vaccines already on the market.